Literature DB >> 22749956

Role of Nox4 in murine models of kidney disease.

Andrea Babelova1, Despina Avaniadi, Oliver Jung, Christian Fork, Janet Beckmann, Judith Kosowski, Norbert Weissmann, Narayana Anilkumar, Ajay M Shah, Liliana Schaefer, Katrin Schröder, Ralf P Brandes.   

Abstract

Nox4 is a hydrogen peroxide-producing NADPH oxidase highly expressed in the kidney which has been linked to epithelial cell injury and diabetic-induced cellular dysfunction in cultured cells. The role of the enzyme for renal pathology in vivo, however, is unclear. To address this, three experimental animal models of renal injury (streptozotocin diabetes I, unilateral ureteral ligation (UUO), and 5/6 nephrectomy (5/6Nx)) were studied in either Nox4-inducible (Nox4(*/*)) or constitutive knockout (Nox4(-/-)) mice. Nox4 contributed more than 80% of diphenylene iodonium-sensitive H(2)O(2) formation of freshly isolated tubules determined by Amplex Red assay. In streptozotocin diabetes, acute deletion of Nox4 by tamoxifen-activated cre-recombinase increased albuminuria, whereas matrix deposition was similar between WT and Nox4(*/*) mice. Interestingly, renal Nox4 expression, mainly localized to tubular cells, decreased in the course of diabetes and this was not associated with a compensatory upregulation of Nox1 or Nox2. In the UUO model, renal expression of ICAM1, connective tissue growth factor, and fibronectin were higher in kidneys of Nox4(*/*) than control mice. Also in this model, levels of Nox4 decreased in the course of the disease. In the 5/6Nx model, which was performed in SV129 and SV129-Nox4(-/-) mice, no difference in the development of hypertension and albuminuria was found between the strains. Collectively, the first in vivo data of the kidney do not support the view that Nox4 is a main driver of renal disease. It rather appears that under specific conditions Nox4 may even slightly limit injury and disease progression.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22749956     DOI: 10.1016/j.freeradbiomed.2012.06.027

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  71 in total

1.  Myocardin-related Transcription Factor Regulates Nox4 Protein Expression: LINKING CYTOSKELETAL ORGANIZATION TO REDOX STATE.

Authors:  Matthew Rozycki; Janne Folke Bialik; Pam Speight; Qinghong Dan; Teresa E T Knudsen; Stephen G Szeto; Darren A Yuen; Katalin Szászi; Stine F Pedersen; András Kapus
Journal:  J Biol Chem       Date:  2015-11-10       Impact factor: 5.157

Review 2.  The pathobiology of diabetic vascular complications--cardiovascular and kidney disease.

Authors:  Stephen P Gray; Karin Jandeleit-Dahm
Journal:  J Mol Med (Berl)       Date:  2014-04-01       Impact factor: 4.599

Review 3.  MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

4.  CTRP1 Attenuates UUO-induced Renal Fibrosis via AMPK/NOX4 Pathway in Mice.

Authors:  Wen Li; Fan Cheng; Yi-Yan Songyang; Song-Yi-Sha Yang; Jie Wei; Yuan Ruan
Journal:  Curr Med Sci       Date:  2020-03-13

Review 5.  Diabetes and Kidney Disease: Role of Oxidative Stress.

Authors:  Jay C Jha; Claudine Banal; Bryna S M Chow; Mark E Cooper; Karin Jandeleit-Dahm
Journal:  Antioxid Redox Signal       Date:  2016-04-01       Impact factor: 8.401

Review 6.  Therapeutic potential of NADPH oxidase 1/4 inhibitors.

Authors:  G Teixeira; C Szyndralewiez; S Molango; S Carnesecchi; F Heitz; P Wiesel; J M Wood
Journal:  Br J Pharmacol       Date:  2016-07-14       Impact factor: 8.739

7.  Hydrogen sulfide inhibits high glucose-induced NADPH oxidase 4 expression and matrix increase by recruiting inducible nitric oxide synthase in kidney proximal tubular epithelial cells.

Authors:  Hak Joo Lee; Doug Yoon Lee; Meenalakshmi M Mariappan; Denis Feliers; Goutam Ghosh-Choudhury; Hanna E Abboud; Yves Gorin; Balakuntalam S Kasinath
Journal:  J Biol Chem       Date:  2017-02-10       Impact factor: 5.157

8.  Role of Nox2 in diabetic kidney disease.

Authors:  Young-Hyun You; Shinichi Okada; San Ly; Karin Jandeleit-Dahm; David Barit; Tamehachi Namikoshi; Kumar Sharma
Journal:  Am J Physiol Renal Physiol       Date:  2013-02-06

Review 9.  Nox4 and diabetic nephropathy: with a friend like this, who needs enemies?

Authors:  Yves Gorin; Karen Block
Journal:  Free Radic Biol Med       Date:  2013-03-23       Impact factor: 7.376

10.  NOX4-derived reactive oxygen species limit fibrosis and inhibit proliferation of vascular smooth muscle cells in diabetic atherosclerosis.

Authors:  Elyse Di Marco; Stephen P Gray; Kit Kennedy; Cedric Szyndralewiez; Alicia N Lyle; Bernard Lassègue; Kathy K Griendling; Mark E Cooper; Harald H H W Schmidt; Karin A M Jandeleit-Dahm
Journal:  Free Radic Biol Med       Date:  2016-07-19       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.